Skip to main content

and
  1. Article

    Open Access

    Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

    Multiple studies have demonstrated that diffuse large B-cell lymphoma (DLBCL) can be divided into subgroups based on their biology; however, these biological subgroups overlap clinically. Using machine learnin...

    Maher Albitar, Hong Zhang, Andre Goy, Zijun Y. Xu-Monette in Blood Cancer Journal (2022)

  2. No Access

    Article

    Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

    Clinical testing of BCR inhibition on DLBCL reveals determinants of response.

    Wyndham H Wilson, Ryan M Young, Roland Schmitz, Yandan Yang in Nature Medicine (2015)